Literature DB >> 8094736

Abnormal in vitro proliferation and differentiation of T cell colony-forming cells in patients with tropical spastic paraparesis/human T lymphocyte virus type I (HTLV-I)-associated myeloencephalopathy and healthy HTLV-I carriers.

Y Lunardi-Iskandar1, A Gessain, V H Lam, R C Gallo.   

Abstract

T cell colonies were generated from the peripheral blood mononuclear cells (PBMC) of 10 patients with tropical spastic paraparesis/human T lymphocyte virus type I (HTLV-I)-associated myeloencephalopathy (TSP/HAM), two healthy HTLV-I carriers, and 17 healthy HTLV-I-seronegative subjects. PBMC were cultured in methylcellulose in the absence of added growth factors (spontaneous T cell colonies), or in the presence of phorbol myristate acetate and interleukin 2 (induced T cell colonies). PBMC T cell colony-forming cells (T-CFC) from all TSP/HAM patients and HTLV-I carriers were able to grow in the absence of added growth factors and/or mitogenic stimulation. Pooled spontaneous and induced colonies were composed of cells bearing CD3+, CD4+, CD8+, and CD1+ antigens. Colonies from normal HTLV-I-seronegative subjects displayed mature cells bearing the CD3+, CD4+, CD8+, and CD1- surface phenotype. In addition, spontaneous and induced T cell colonies expressed HTLV-I antigens in 18-38% of the cells from TSP/HAM patients and HTLV-I carriers. These results demonstrate that HTLV-I infection is associated with an abnormal proliferation and differentiation of T cell progenitors in vitro and that the T-CFC from HTLV-I-seropositive individuals are infected, suggesting that T-CFC abnormalities may play a predominant role in the pathophysiology of HTLV-I.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8094736      PMCID: PMC2190926          DOI: 10.1084/jem.177.3.741

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  33 in total

1.  Clonal proliferation of PHA-stimulated human lymphocytes in soft agar culture.

Authors:  L A Rozenszajn; D Shoham; I Kalechman
Journal:  Immunology       Date:  1975-12       Impact factor: 7.397

2.  Adult T-cell leukemia: clinical and hematologic features of 16 cases.

Authors:  T Uchiyama; J Yodoi; K Sagawa; K Takatsuki; H Uchino
Journal:  Blood       Date:  1977-09       Impact factor: 22.113

3.  Colony formation by human T lymphocytes in agar medium.

Authors:  M H Claësson; M B Rodger; G R Johnson; S Whittingham; D Metcalf
Journal:  Clin Exp Immunol       Date:  1977-06       Impact factor: 4.330

4.  Isolation of a new type C retrovirus (HTLV) in primary uncultured cells of a patient with Sézary T-cell leukaemia.

Authors:  B J Poiesz; F W Ruscetti; M S Reitz; V S Kalyanaraman; R C Gallo
Journal:  Nature       Date:  1981-11-19       Impact factor: 49.962

5.  A methodological study of E-rosette formation using AET-treated sheep red blood cells.

Authors:  M Madsen; H E Johnsen
Journal:  J Immunol Methods       Date:  1979-05-10       Impact factor: 2.303

6.  Existence of a pool of T-lymphocyte colony-forming cells (T-CFC) in human bone marrow and their place in the differentiation of the T-lymphocyte lineage.

Authors:  F Triebel; W A Robinson; A R Hayward; P G Goube de Laforest
Journal:  Blood       Date:  1981-11       Impact factor: 22.113

7.  Depressed T cell colony growth in systemic lupus erythematosus.

Authors:  M L Bernstein; A Winkelstein; S A Dobson
Journal:  Arthritis Rheum       Date:  1980-04

8.  T-lymphocyte colonies in malignant disease.

Authors:  D C Sutherland; G Dalton; J D Wilson
Journal:  Lancet       Date:  1976-11-20       Impact factor: 79.321

9.  Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera.

Authors:  Y Hinuma; K Nagata; M Hanaoka; M Nakai; T Matsumoto; K I Kinoshita; S Shirakawa; I Miyoshi
Journal:  Proc Natl Acad Sci U S A       Date:  1981-10       Impact factor: 11.205

10.  Human T-cell leukemia-lymphoma virus type I (HTLV-I) expression in fresh peripheral blood mononuclear cells from patients with tropical spastic paraparesis/HTLV-I-associated myelopathy.

Authors:  A Gessain; A Louie; O Gout; R C Gallo; G Franchini
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

View more
  10 in total

1.  Autocrine/paracrine cytokine stimulation of leukemic cell proliferation in smoldering and chronic adult T-cell leukemia.

Authors:  Jing Chen; Mike Petrus; Bonita R Bryant; Vinh Phuc Nguyen; Carolyn K Goldman; Richard Bamford; John C Morris; John E Janik; Thomas A Waldmann
Journal:  Blood       Date:  2010-09-21       Impact factor: 22.113

2.  Human T cell leukaemia/lymphoma virus and blood donation.

Authors:  A G Dalgleish
Journal:  BMJ       Date:  1993-11-13

Review 3.  Molecular biology and pathogenesis of the human T-cell leukaemia/lymphotropic virus Type-1 (HTLV-1).

Authors:  J M Johnson; R Harrod; G Franchini
Journal:  Int J Exp Pathol       Date:  2001-06       Impact factor: 1.925

4.  CP-690,550, a therapeutic agent, inhibits cytokine-mediated Jak3 activation and proliferation of T cells from patients with ATL and HAM/TSP.

Authors:  Wei Ju; Meili Zhang; Jian-kang Jiang; Craig J Thomas; Unsong Oh; Bonita R Bryant; Jing Chen; Noriko Sato; Yutaka Tagaya; John C Morris; John E Janik; Steven Jacobson; Thomas A Waldmann
Journal:  Blood       Date:  2010-11-24       Impact factor: 22.113

5.  Adhesion-dependent growth of primary adult T cell leukemia cells with down-regulation of HTLV-I p40Tax protein: a novel in vitro model of the growth of acute ATL cells.

Authors:  Kazuhiro Nagai; Itsuro Jinnai; Tomoko Hata; Tetsuya Usui; Daisuke Sasaki; Kunihiro Tsukasaki; Kazuyuki Sugahara; Yoshitaka Hishikawa; Yasuaki Yamada; Yuetsu Tanaka; Takehiko Koji; Hiroyuki Mano; Shimeru Kamihira; Masao Tomonaga
Journal:  Int J Hematol       Date:  2008-12-02       Impact factor: 2.490

6.  Phase 1 trial of IL-15 trans presentation blockade using humanized Mikβ1 mAb in patients with T-cell large granular lymphocytic leukemia.

Authors:  Thomas A Waldmann; Kevin C Conlon; Donn M Stewart; TatYana A Worthy; John E Janik; Thomas A Fleisher; Paul S Albert; William D Figg; Shawn D Spencer; Mark Raffeld; Jean R Decker; Carolyn K Goldman; Bonita R Bryant; Michael N Petrus; Stephen P Creekmore; John C Morris
Journal:  Blood       Date:  2012-12-03       Impact factor: 22.113

7.  Induction of the IL-9 gene by HTLV-I Tax stimulates the spontaneous proliferation of primary adult T-cell leukemia cells by a paracrine mechanism.

Authors:  Jing Chen; Mike Petrus; Bonita R Bryant; Vinh Phuc Nguyen; Mindy Stamer; Carolyn K Goldman; Richard Bamford; John C Morris; John E Janik; Thomas A Waldmann
Journal:  Blood       Date:  2008-03-13       Impact factor: 22.113

8.  Spontaneous lymphocyte proliferation in human T-cell lymphotropic virus type I (HTLV-I) and HTLV-II infection: T-cell subset responses and their relationships to the presence of provirus and viral antigen production.

Authors:  H E Prince; J York; J Golding; S M Owen; R B Lal
Journal:  Clin Diagn Lab Immunol       Date:  1994-05

9.  Suppression of lymphocyte spontaneous proliferative response by proteolipid protein peptide in patients with HAM/TSP.

Authors:  T Tabira; J Inobe; K Nakahara; M Osame; T Yamamura
Journal:  Neurochem Res       Date:  1994-08       Impact factor: 3.996

10.  Detection of human T lymphotrophic virus type I (HTLV-I) proviral DNA and analysis of T cell receptor V beta CDR3 sequences in spinal cord lesions of HTLV-I-associated myelopathy/tropical spastic paraparesis.

Authors:  H Hara; M Morita; T Iwaki; T Hatae; Y Itoyama; T Kitamoto; S Akizuki; I Goto; T Watanabe
Journal:  J Exp Med       Date:  1994-09-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.